Assertio Holdings, Inc.
ASRT
Assertio Holdings, Inc., a specialty pharmaceutical company, provides medicines in the areas of neurology, hospital, and pain and inflammation. Its pharmaceutical products include INDOCIN, an oral solution and a suppository form for the treatment of moderate to severe rheumatoid arthritis, including acute flares of chronic disease; ankylosing spondylitis and osteoarthritis; and acute painful shoulā¦ read more
Healthcare
Drug ManufacturersāSpecialty & Generic
27 years
USD
Exclusive to Premium users
Price
per share adjusted in USD$0.76
Price+0.01%
$0.00
1Y
Price
Market Cap
$73.190m
Small
Price/Earnings 3y Avg5y Avg
-
Premium
Premium
Financials Overview
Key metrics over the past few years-21.8%
EBITDA Margin-56.0%
Net Profit Margin+65.3%
Free Cash Flow MarginRevenue
$117.096m
-6.3%
1y CAGR-8.9%
3y CAGR+3.5%
5y CAGREarnings
-$42.800m
-98.3%
1y CAGR-135.9%
3y CAGR+2062.5%
5y CAGREPS
-$0.45
-95.6%
1y CAGR-110.2%
3y CAGR+1634.0%
5y CAGRBook Value
$93.298m
$273.780m
Assets$180.482m
Liabilities$45.786m
DebtDebt to Assets
16.7%
-2.5x
Debt to EBITDAFree Cash Flow
$18.066m
-31.6%
1y CAGR-38.4%
3y CAGR+304.2%
5y CAGRFinancial Reports
Earnings and other important metrics. Amounts in USD.No items found.
Press Releases
Statements and updates from the company